HDMS Case Study: Three Cost Containment Strategies for GLP-1 Drugs

Why rising GLP-1 costs aren’t going away and what to do about it.  Read more in the HDMS case study.

HDMS-GLP-1-Analytics-case-study

Latest Posts
Partner News
Elevance Health: Surveying Food as Medicine Initiatives
Increasing prevalence of diet-related health conditions indicates the concept of Food as Medicine (FAM) is ...
Read More
Blog
2025 Trends in Employee Benefits
Alison Main, Director at Silicon Valley Employers Forum   As organizations adapt to the changing ...
Read More
Partner News
Novo Nordisk – Think You Know the Truth About Compounded “Semaglutide”?
At Novo Nordisk, patient safety is a top priority.  As the sole manufacturer of FDA-approved ...
Read More
Follow SVEF
Scroll to Top

Join the Mailing List

Contact the Team

You must be logged in to fill out this form.

Ad Hoc Survey Request

You must be logged in to fill out this form.